Methylene Blue and RAD-140 Interaction

Avoid
Mechanism-based 53% confidence

Methylene Blue and RAD-140 have a potentially harmful interaction with 53% confidence. Both Methylene Blue and RAD-140 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.

Compound Profiles

Methylene Blue

Mitochondrial Electron Carrier | Cognitive & Neuroprotection

Methylene blue functions as a redox cycling agent in mitochondria. In its oxidized form, it accepts electrons from NADH through Complex I and is reduced to leucomethylene blue.

Half-life: ~5-6 hours Typical dose: 0.5-2 mg/kg oral (low-dose nootropic) cognitive, longevity
dopamine receptorserotonin receptor blood pressure raisinghepatotoxicphotosensitizingserotonergic
View full profile

RAD-140

Selective Androgen Receptor Modulator | Investigational SARM

RAD-140 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a full agonist in muscle and bone tissue while exhibiting minimal agonist activity in the prostate and other androgen-sensitive tissues. This tissue selectivity is achieved through differential cofactor recruitment: upon binding to the AR, RAD-140 induces a conformational change that favors interaction with coactivators predominantly expressed in skeletal muscle and bone, rather than those prevalent in prostate or sebaceous glands.

Half-life: ~60 hours Typical dose: 10-20 mg/day sarm, anabolic
androgen receptorepo receptor androgenicblood pressure raisingcarcinogenic riskcrosses bbb
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Brain
low

Shared Safety Flags

2x 2 compounds raise blood pressure (Methylene Blue, RAD-140). Monitor BP daily and consider cardiovascular support.
2x 2 hepatotoxic compounds (Methylene Blue, RAD-140). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.

Frequently Asked Questions

Can I take Methylene Blue with RAD-140?

Combining Methylene Blue with RAD-140 is not recommended. Both Methylene Blue and RAD-140 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Methylene Blue and RAD-140 safe together?

This combination carries significant risk. Both Methylene Blue and RAD-140 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Methylene Blue and RAD-140?

Both Methylene Blue and RAD-140 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 53% confidence and is inferred from pharmacological mechanism analysis.

How should I time Methylene Blue and RAD-140?

Methylene Blue has a half-life of ~5-6 hours and RAD-140 has a half-life of ~60 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Methylene Blue vs RAD-140

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.